Jun 20, 2018
By Michael Kramer
A subsidiary of Ontario Power Generation is partnering with an American company – to produce the radioactive isotopes used to diagnose cancer, heart disease and other conditions.
The Crown corporation says CANDU reactors at its Darlington nuclear plant in Clarington – can produce molybdenum-99.. while still generating electricity.
Molybdenum-99 is needed to make the isotope technetium-99 for medical imaging.
Canada’s domestic supply of medical isotopes was disrupted – after the Chalk River reactor ceased production in 2016 – requiring hospitals to import the material from Europe, Africa and Australia.
Production at Darlington is expected to start by the end of 2019.